Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of Labor
This study is currently recruiting participants.
Verified December 2012 by Regenex Pharmaceutical, China
Study NCT01428037   Information provided by Regenex Pharmaceutical, China

First Received on August 31, 2011.   Last Updated on December 3, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cervical Ripening
Induction of Labor
Interventions listed in this trial
Placebo
Misoprostol vaginal Tablet 25 mcg
Additional drug interventions recognized in this trial
Misoprostol
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Anti-Ulcer Agents
Gastrointestinal Agents
Oxytocics
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Regenex Pharmaceutical, China


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services